Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Randomised Double-blind Placebo-controlled Trial to Assess Safety, Efficacy of Artesunate & Curcumin in Crohn's Disease Patients, Who Continue to Have Mild to Moderate Disease Activity on an Adequate Dose of Azathioprine

NCT04713631 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT04713631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Randomised Double-blind Placebo-controlled Trial to Assess Safety, Efficacy of Artesunate & Curcumin in Crohn's Disease Patients, Who Continue to Have Mild to Moderate Disease Activity on an Adequate Dose of Azathioprine
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
January 21, 2021
Completion date
January 31, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease